SomnoMed Limited (SOMNF)

Market Cap	44.02M -59.5%
Revenue (ttm)	79.23M +2.7%
Net Income	-1.83M
EPS	-0.01
Shares Out	n/a
PE Ratio	n/a
Forward PE	15.03
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,000
Open	0.1647
Previous Close	n/a
Day's Range	0.1647 - 0.1806
52-Week Range	0.1647 - 0.5149
Beta	0.78
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About SomnoMed

SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. The company offers SomnoDent, such as SomnoDent Avant, SomnoDent Classic, SomnoDent Flex, herbst advance, and SomnoDent Fusion for the treatment of obstructive sleep apnea. It also provides SomMorning Repositioner, a product designed to help return patient’s mandible back to its pre-treatment centric position; SomnoBrux splint, a custom fit, acrylic splint for patien...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1987
• Employees: 300
• Stock Exchange: OTCMKTS
• Ticker Symbol: SOMNF

Financial Performance

In fiscal year 2026, SomnoMed's revenue was 114.53 million, an increase of 2.73% compared to the previous year's 111.49 million. Losses were -2.65 million, -23.32% less than in 2025.

Financial numbers in AUD

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Nov 9, 2026

Data Sources Report a data error